| 4LMQ: reference: Development and Preclinical Characterization of a Humanized Antibody Targeting CXCL12., Zhong C, Wang J, Li B, Xiang H, Ultsch M, Coons M, Wong T, Chiang NY, Clark S, Clark R, Quintana L, Gribling P, Suto E, Barck K, Corpuz R, Yao J, Takkar R, Lee WP, Damico-Beyer LA, Carano RD, Adams C, Kelley RF, Wang W, Ferrara N, Clin Cancer Res. 2013 Jul 15. PMID: 23812669 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).